These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35766041)

  • 21. Systolic blood pressure trajectory and cardiovascular outcomes: An analysis using data in the Systolic Blood Pressure Intervention Trial.
    Lee CL; Wang JS
    Int J Clin Pract; 2020 Mar; 74(3):e13450. PubMed ID: 31755625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive Blood Pressure Treatment Goals: Evidence for Cardiovascular Protection From Observational Studies and Clinical Trials.
    Whelton PK; Bundy JD; Carey RM
    Am J Hypertens; 2022 Nov; 35(11):905-914. PubMed ID: 35390116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial.
    Jaeger BC; Bress AP; Bundy JD; Cheung AK; Cushman WC; Drawz PE; Johnson KC; Lewis CE; Oparil S; Rocco MV; Rapp SR; Supiano MA; Whelton PK; Williamson JD; Wright JT; Reboussin DM; Pajewski NM
    JAMA Cardiol; 2022 Nov; 7(11):1138-1146. PubMed ID: 36223105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Wang KM; Stedman MR; Chertow GM; Chang TI
    Hypertension; 2020 Dec; 76(6):1725-1733. PubMed ID: 33131314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).
    Shapiro BP; Ambrosius WT; Blackshear JL; Cushman WC; Whelton PK; Oparil S; Beddhu S; Dwyer JP; Gren LH; Kostis WJ; Lioudis M; Pisoni R; Rosendorff C; Haley WE;
    Hypertension; 2018 Jun; 71(6):1064-1074. PubMed ID: 29712745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults.
    Derington CG; Bress AP; Berchie RO; Herrick JS; Shen J; Ying J; Greene T; Tajeu GS; Sakhuja S; Ruiz-Negrón N; Zhang Y; Howard G; Levitan EB; Muntner P; Safford MM; Whelton PK; Weintraub WS; Moran AE; Bellows BK
    Am J Hypertens; 2023 Aug; 36(9):498-508. PubMed ID: 37378472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation.
    Soliman EZ; Rahman AF; Zhang ZM; Rodriguez CJ; Chang TI; Bates JT; Ghazi L; Blackshear JL; Chonchol M; Fine LJ; Ambrosius WT; Lewis CE
    Hypertension; 2020 Jun; 75(6):1491-1496. PubMed ID: 32362229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive systolic blood pressure treatment remodels brain perivascular spaces: A secondary analysis of the Systolic Pressure Intervention Trial (SPRINT).
    Kern KC; Nasrallah IM; Bryan RN; Reboussin DM; Wright CB
    Neuroimage Clin; 2023; 40():103513. PubMed ID: 37774646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
    Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
    JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial.
    Sheppard JP; Burt J; Lown M; Temple E; Lowe R; Fraser R; Allen J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Kodabuckus S; Little P; Mant J; Mollison J; Payne RA; Williams M; Yu LM; McManus RJ;
    JAMA; 2020 May; 323(20):2039-2051. PubMed ID: 32453368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Pajewski NM; Berlowitz DR; Bress AP; Callahan KE; Cheung AK; Fine LJ; Gaussoin SA; Johnson KC; King J; Kitzman DW; Kostis JB; Lerner AJ; Lewis CE; Oparil S; Rahman M; Reboussin DM; Rocco MV; Snyder JK; Still C; Supiano MA; Wadley VG; Whelton PK; Wright JT; Williamson JD
    J Am Geriatr Soc; 2020 Mar; 68(3):496-504. PubMed ID: 31840813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.
    Berlowitz DR; Foy CG; Kazis LE; Bolin LP; Conroy MB; Fitzpatrick P; Gure TR; Kimmel PL; Kirchner K; Morisky DE; Newman J; Olney C; Oparil S; Pajewski NM; Powell J; Ramsey T; Simmons DL; Snyder J; Supiano MA; Weiner DE; Whittle J;
    N Engl J Med; 2017 Aug; 377(8):733-744. PubMed ID: 28834483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
    JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.
    Inoue K; Watson KE; Kondo N; Horwich T; Hsu W; Bui AAT; Duru OK
    JAMA Netw Open; 2022 Mar; 5(3):e222037. PubMed ID: 35285922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering: Results From the STEP Randomized Trial.
    Yang R; Huang R; Zhang L; Li D; Luo J; Cai J
    Hypertension; 2023 Dec; 80(12):2572-2580. PubMed ID: 37814892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm.
    Kalkman DN; Brouwer TF; Vehmeijer JT; Berger WR; Knops RE; de Winter RJ; Peters RJ; van den Born BH
    Circulation; 2017 Dec; 136(23):2220-2229. PubMed ID: 28939617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
    Upadhya B; Rocco M; Lewis CE; Oparil S; Lovato LC; Cushman WC; Bates JT; Bello NA; Aurigemma G; Fine LJ; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental effects of antihypertensive drugs: instrumental variable analysis.
    Markovitz AA; Mack JA; Nallamothu BK; Ayanian JZ; Ryan AM
    BMJ; 2017 Dec; 359():j5542. PubMed ID: 29273586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.